×
About 576 results

ALLMedicine™ Sleepwalking Center

Research & Reviews  251 results

Association of Sleepwalking and REM Sleep Behavior Disorder With Parkinson Disease in Men.
https://doi.org/10.1001/jamanetworkopen.2021.5713
JAMA Network Open; Zhang X, Molsberry SA et. al.

Apr 13th, 2021 - Previous studies conducted among patients with Parkinson disease (PD) reported that parasomnias other than rapid eye movement (REM) sleep behavior disorder (RBD), particularly sleepwalking (SW), are associated with PD severity. However, it remains...

Tapentadol and Sleepwalking: A Case Report.
https://doi.org/10.1177/0897190021996975
Journal of Pharmacy Practice; Ko EYJ, Tupper MW

Feb 24th, 2021 - This is a case report of a patient with sleepwalking likely caused by tapentadol ER secondary to higher than the recommended dose for the treatment of pain. This report presents the relevant patient history, laboratory data and literature review o...

The Arousal Disorders Questionnaire: a new and effective screening tool for confusional...
https://doi.org/10.1016/j.sleep.2021.01.037
Sleep Medicine; Loddo G, La Fauci G et. al.

Feb 20th, 2021 - Arousal Disorders (DoA) include Confusional Arousals, Sleepwalking and Sleep Terrors. DoA diagnosis is mainly clinical but no validated questionnaires exist for DoA screening according to the criteria of the International Classification of Sleep D...

NonREM Disorders of Arousal and Related Parasomnias: an Updated Review.
https://doi.org/10.1007/s13311-021-01011-y 10.1016/j.sleep.2005.12.006 10.1093/sleep/30.6.683 10.1097/MCP.0000000000000321 10.5664/jcsm.2036 10.1212/wnl.10.9.868 10.1212/WNL.48.1.177 10.2165/0023210-200822120-00005 10.1093/sleep/25.8.32 10.1212/01.wnl.0000304082.49839.86 10.1080/00048670902817703 10.1016/s1389-9457(02)00007-2 10.1097/01.chi.0000129219.66563.aa 10.5664/JCSM.1082 10.1345/aph.10073 10.1097/JCP.0b013e3181c9c8a2 10.4088/jcp.v64n0420e 10.1097/00004850-199905030-00004 10.1017/s1092852900015698 10.4088/jcp.v63n0710d 10.1016/j.pnpbp.2007.10.006 10.1097/00006454-199905000-00024 10.1212/01.wnl.0000180937.20774.20 10.1176/ajp.136.9.1214 10.1016/j.jsmc.2019.05.002 10.1016/j.smrv.2005.12.004 10.1152/physrev.1988.68.3.649 10.4088/jcp.v60n0413 10.1007/s11910-005-0014-3 10.1097/00004691-199503000-00005 10.1097/00004691-199803000-00010 10.1016/s1388-2457(00)00249-2 10.1093/brain/awh481 10.1093/sleep/23.6.1d 10.1016/s0022-3999(01)00187-8 10.1111/j.1365-2869.2004.00404.x 10.1016/j.sleep.2005.03.003 10.1093/sleep/32.3.409 10.1016/S0140-6736(00)02561-7 10.1007/s10072-005-0492-8 10.1016/j.neurol.2009.08.002 10.1093/brain/120.7.1173 10.1016/j.mehy.2004.06.013 10.1016/s0140-6736(05)62351-3 10.1093/sleep/29.7.949 10.1016/s0165-0173(02)00187-x 10.1017/s0033291799008272 10.1093/sleep/29.7.949 10.1093/sleep/14.5.419 10.1136/jnnp.2006.096131 10.1192/bjp.139.1.79a 10.1097/JCP.0000000000000502 10.4088/JCP.09l05364bro 10.5664/jcsm.27132 10.4088/JCP.09l05623gry 10.4088/JCP.09m05083bro 10.1002/mds.22460 10.1016/B978-0-444-64142-7.00063-1 10.1212/WNL.10.9.868 10.1001/archinte.164.2.196 10.1001/archinte.165.11.1286 10.1002/mds.21824 10.1177/154411130301400104 10.1002/mds.870100517 10.1016/j.sleep.2009.05.016 10.1212/01.wnl.0000252368.25106.b6 10.1002/mds.22797 10.1007/BF00216064 10.1111/j.1468-1331.2005.01017.x 10.2165/00003495-200059040-00014 10.2165/00023210-200216120-00002 10.1176/ajp.146.9.1166 10.1111/jsr.12772 10.1080/14737175.2018.1510773 10.1080/07420528.2016.1184678 10.1016/j.sleep.2018.03.021 10.1001/jama.295.24.2851 10.1016/S0002-9343(97)89493-4 10.3109/10401239409148998 10.5664/jcsm.7404 10.1097/00005053-199104000-00009 10.5664/jcsm.26858 10.1080/15402002.2017.1292726 10.1080/00325481.2019.1697119 10.1016/j.smrv.2008.09.003 10.1212/WNL.40.5.749 10.1002/eat.2260150405 10.1016/s1389-9457(03)00060-1 10.4088/jcp.v67n1109 10.5664/jcsm.7404 10.1016/j.sleep.2016.04.017 10.1016/j.sleep.2013.06.012 10.1093/sleep/14.1.69 10.1016/j.nrl.2017.05.004 10.1016/j.smrv.2015.07.003
Neurotherapeutics : the Journal of the American Society F... Irfan M, Schenck CH et. al.

Feb 2nd, 2021 - Parasomnias are abnormal behaviors and/or experiences emanating from or associated with sleep typically manifesting as motor movements of varying semiology. We discuss mainly nonrapid eye movement sleep and related parasomnias in this article. Sle...

Overdose and Alcohol Sensitive Immediate Release System (OASIS) for Deterring Accidenta...
https://doi.org/10.1208/s12249-020-01879-7
AAPS PharmSciTech; Patki M, Palekar S et. al.

Nov 26th, 2020 - Death from an accidental or intentional overdose of sleeping tablets has increased exponentially in the USA. Furthermore, the simultaneous consumption of sleeping tablets with alcoholic beverages not only intensifies the effect of sleeping tablets...

see more →

Clinicaltrials.gov  291 results

Association of Sleepwalking and REM Sleep Behavior Disorder With Parkinson Disease in Men.
https://doi.org/10.1001/jamanetworkopen.2021.5713
JAMA Network Open; Zhang X, Molsberry SA et. al.

Apr 13th, 2021 - Previous studies conducted among patients with Parkinson disease (PD) reported that parasomnias other than rapid eye movement (REM) sleep behavior disorder (RBD), particularly sleepwalking (SW), are associated with PD severity. However, it remains...

Tapentadol and Sleepwalking: A Case Report.
https://doi.org/10.1177/0897190021996975
Journal of Pharmacy Practice; Ko EYJ, Tupper MW

Feb 24th, 2021 - This is a case report of a patient with sleepwalking likely caused by tapentadol ER secondary to higher than the recommended dose for the treatment of pain. This report presents the relevant patient history, laboratory data and literature review o...

The Arousal Disorders Questionnaire: a new and effective screening tool for confusional...
https://doi.org/10.1016/j.sleep.2021.01.037
Sleep Medicine; Loddo G, La Fauci G et. al.

Feb 20th, 2021 - Arousal Disorders (DoA) include Confusional Arousals, Sleepwalking and Sleep Terrors. DoA diagnosis is mainly clinical but no validated questionnaires exist for DoA screening according to the criteria of the International Classification of Sleep D...

NonREM Disorders of Arousal and Related Parasomnias: an Updated Review.
https://doi.org/10.1007/s13311-021-01011-y 10.1016/j.sleep.2005.12.006 10.1093/sleep/30.6.683 10.1097/MCP.0000000000000321 10.5664/jcsm.2036 10.1212/wnl.10.9.868 10.1212/WNL.48.1.177 10.2165/0023210-200822120-00005 10.1093/sleep/25.8.32 10.1212/01.wnl.0000304082.49839.86 10.1080/00048670902817703 10.1016/s1389-9457(02)00007-2 10.1097/01.chi.0000129219.66563.aa 10.5664/JCSM.1082 10.1345/aph.10073 10.1097/JCP.0b013e3181c9c8a2 10.4088/jcp.v64n0420e 10.1097/00004850-199905030-00004 10.1017/s1092852900015698 10.4088/jcp.v63n0710d 10.1016/j.pnpbp.2007.10.006 10.1097/00006454-199905000-00024 10.1212/01.wnl.0000180937.20774.20 10.1176/ajp.136.9.1214 10.1016/j.jsmc.2019.05.002 10.1016/j.smrv.2005.12.004 10.1152/physrev.1988.68.3.649 10.4088/jcp.v60n0413 10.1007/s11910-005-0014-3 10.1097/00004691-199503000-00005 10.1097/00004691-199803000-00010 10.1016/s1388-2457(00)00249-2 10.1093/brain/awh481 10.1093/sleep/23.6.1d 10.1016/s0022-3999(01)00187-8 10.1111/j.1365-2869.2004.00404.x 10.1016/j.sleep.2005.03.003 10.1093/sleep/32.3.409 10.1016/S0140-6736(00)02561-7 10.1007/s10072-005-0492-8 10.1016/j.neurol.2009.08.002 10.1093/brain/120.7.1173 10.1016/j.mehy.2004.06.013 10.1016/s0140-6736(05)62351-3 10.1093/sleep/29.7.949 10.1016/s0165-0173(02)00187-x 10.1017/s0033291799008272 10.1093/sleep/29.7.949 10.1093/sleep/14.5.419 10.1136/jnnp.2006.096131 10.1192/bjp.139.1.79a 10.1097/JCP.0000000000000502 10.4088/JCP.09l05364bro 10.5664/jcsm.27132 10.4088/JCP.09l05623gry 10.4088/JCP.09m05083bro 10.1002/mds.22460 10.1016/B978-0-444-64142-7.00063-1 10.1212/WNL.10.9.868 10.1001/archinte.164.2.196 10.1001/archinte.165.11.1286 10.1002/mds.21824 10.1177/154411130301400104 10.1002/mds.870100517 10.1016/j.sleep.2009.05.016 10.1212/01.wnl.0000252368.25106.b6 10.1002/mds.22797 10.1007/BF00216064 10.1111/j.1468-1331.2005.01017.x 10.2165/00003495-200059040-00014 10.2165/00023210-200216120-00002 10.1176/ajp.146.9.1166 10.1111/jsr.12772 10.1080/14737175.2018.1510773 10.1080/07420528.2016.1184678 10.1016/j.sleep.2018.03.021 10.1001/jama.295.24.2851 10.1016/S0002-9343(97)89493-4 10.3109/10401239409148998 10.5664/jcsm.7404 10.1097/00005053-199104000-00009 10.5664/jcsm.26858 10.1080/15402002.2017.1292726 10.1080/00325481.2019.1697119 10.1016/j.smrv.2008.09.003 10.1212/WNL.40.5.749 10.1002/eat.2260150405 10.1016/s1389-9457(03)00060-1 10.4088/jcp.v67n1109 10.5664/jcsm.7404 10.1016/j.sleep.2016.04.017 10.1016/j.sleep.2013.06.012 10.1093/sleep/14.1.69 10.1016/j.nrl.2017.05.004 10.1016/j.smrv.2015.07.003
Neurotherapeutics : the Journal of the American Society F... Irfan M, Schenck CH et. al.

Feb 2nd, 2021 - Parasomnias are abnormal behaviors and/or experiences emanating from or associated with sleep typically manifesting as motor movements of varying semiology. We discuss mainly nonrapid eye movement sleep and related parasomnias in this article. Sle...

Overdose and Alcohol Sensitive Immediate Release System (OASIS) for Deterring Accidenta...
https://doi.org/10.1208/s12249-020-01879-7
AAPS PharmSciTech; Patki M, Palekar S et. al.

Nov 26th, 2020 - Death from an accidental or intentional overdose of sleeping tablets has increased exponentially in the USA. Furthermore, the simultaneous consumption of sleeping tablets with alcoholic beverages not only intensifies the effect of sleeping tablets...

see more →

News  19 results

Certain Prescription Insomnia Medicines: New Boxed Warning - Due to Risk of Serious Injuries Caused by Sleepwalking, Sleep Driving and Engaging in Other Activities While Not Fully Awake | FDA
https://www.fda.gov/safety/medical-product-safety-information/certain-prescription-insomnia-medicines-new-boxed-warning-due-risk-serious-injuries-caused

[Posted 04/30/2019] AUDIENCE: Patient, Health Professional, Pharmacy ISSUE: FDA is advising that rare but serious injuries have happened with certain common prescription insomnia medicines because of sleep behaviors, including sleepwalking, sleep ...

FDA Adds Boxed Warning to Insomnia Drugs
https://www.medscape.com/viewarticle/912402

Apr 29th, 2019 - The US Food and Drug Administration (FDA) is adding a boxed warning to certain prescription insomnia medication following reports of injury and death resulting from sleepwalking, sleep driving, and engaging in other activities while not fully awak...

Sleepwalking: The Science, Cures, and Consequences
https://www.medscape.com/viewarticle/866383

Jul 25th, 2016 - A History of Sleepwalking Editor's Note: Pondered by Galen, Hippocrates, and Shakespeare, sleepwalking has piqued the interest of thinkers for millennia. And though the condition is often benign, sleepwalking can signal a more serious underlying m...

Sleepwalking: The Science, Cures, and Consequences
https://www.medscape.com/viewarticle/866383_5

Jul 25th, 2016 - Rare but Substantial Risks Medscape: Is sleepwalking always considered pathologic? Or is there a benign form in which patients simply deal with it? Dr Howell: Oh, absolutely. The vast majority of sleepwalking is usually pretty benign. In most kids...

see more →

Patient Education  15 results see all →